Authors:
CALVO R
PIFARRE A
ROSELL R
SANCHEZ JJ
MONZO M
RIBERA JM
FELIU E
Citation: R. Calvo et al., H-RAS-1 MINISATELLITE RARE ALLELES - A GENETIC SUSCEPTIBILITY AND PROGNOSTIC FACTOR FOR NON-HODGKINS-LYMPHOMA, Journal of the National Cancer Institute, 90(14), 1998, pp. 1095-1098
Authors:
FELIP E
MASSUTI B
CAMPS C
BENITO D
ISLA D
GONZALEZLARRIBA JL
LOPEZCABRERIZO MP
SALAMANCA O
PUERTOPICA J
MOYANO A
BASELGA J
ROSELL R
Citation: E. Felip et al., SUPERIORITY OF SEQUENTIAL VERSUS CONCURRENT ADMINISTRATION OF PACLITAXEL WITH ETOPOSIDE IN ADVANCED NONSMALL CELL LUNG-CANCER - COMPARISON OF 2 PHASE-II TRIALS, Clinical cancer research, 4(11), 1998, pp. 2723-2728
Citation: C. Martin et al., PREOPERATIVE CHEMOTHERAPY WITH CISPLATIN, 100 MG M(2) VERSUS 50 MG/M(2) IN STAGE IIIA (N2) NONSMALL CELL LUNG-CANCER (NSCLC) - A RANDOMIZEDSTUDY BY THE SPANISH LUNG-CANCER GROUP/, European journal of cancer, 34, 1998, pp. 138-138
Authors:
PELEGRI A
BARNADAS A
ESCOBEDO A
RIFA J
MARTIN J
LAINEZ N
GIL M
BELLET M
ROSELL R
BORRAS J
Citation: A. Pelegri et al., ADJUVANT DOX -] CMF IN PATIENTS WITH BREAST-CANCER (BC) AND 4 OR MOREPOSITIVE NODES (GREATER-THAN-OR-EQUAL-TO-4- CAN MILAN TRIAL RESULTS BE REPRODUCED IN CLINICAL SETTING(LN) ), Annals of oncology, 9, 1998, pp. 27-27
Authors:
ROSELL R
CARDENAL F
MONTES A
ARTAL A
CARRATO A
LOMAS M
ALBEROLA V
BARNETTO I
MASSUTI B
LIEPA AM
Citation: R. Rosell et al., QUALITY-OF-LIFE IN NONSMALL CELL LUNG-CANCER PATIENTS RECEIVING GEMCITABINE (GEMZAR(R)) PLUS CISPLATIN OR ETOPOSIDE PLUS CISPLATIN, Annals of oncology, 9, 1998, pp. 403-403
Authors:
MARTIN C
FONT A
LEE JS
GONZALEZLARRIBA JL
ALBEROLA V
MONZO M
ROSELL R
Citation: C. Martin et al., PACLITAXEL RESISTANCE IN NONSMALL CELL LUNG-CANCER ASSOCIATED WITH BETA-TUBULIN GENE-MUTATIONS, Annals of oncology, 9, 1998, pp. 410-410
Authors:
MONZO M
GUMERLOCK P
SHI XB
MARTIN G
GOMEZCODINA J
PIFARRE A
ASTUDILLO J
GANDARA D
ROSELL R
Citation: M. Monzo et al., HIGH-FREQUENCY OF P53 MUTATIONS IN NONSMALL CELL LUNG-CANCER DETECTEDWITH YEAST FUNCTIONAL ASSAY, Annals of oncology, 9, 1998, pp. 423-423
Authors:
PIFARRE A
MONZO M
MARTIN C
SANCHEZ JJ
BARNADAS A
ROSELL R
Citation: A. Pifarre et al., CLINICAL IMPLICATIONS OF TELOMERASE ACTIVITY IN NONSMALL CELL LUNG-CANCER (NSCLC), Annals of oncology, 9, 1998, pp. 444-444
Authors:
ROSELL R
SACRISTAN JA
DUTHIE T
CARDENAL F
ARTAL A
CARRATO A
LOMAS M
BARNETO I
BAMETO I
MASSUTI B
Citation: R. Rosell et al., COST-EFFECTIVENESS OF GEMCITABINE (GEMZAR(TM)) PLUS CISPLATIN VERSUS ETOPOSIDE PLUS CISPLATIN FOR ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) IN SPAIN, Annals of oncology, 9, 1998, pp. 445-445
Authors:
BALANA C
MONZO M
MARTIN C
LOPEZ MP
NUNEZ L
ROSELL R
Citation: C. Balana et al., A PHASE-II STUDY OF SEQUENCE-DEPENDENT DOCETAXEL (D) VINORELBINE(V) DNA DAMAGE-INDUCED APOPTOSIS IN PATIENTS WITH NONSMALL CELL LUNG-CANCER(NSCLC)/, Annals of oncology, 9, 1998, pp. 482-482
Authors:
SANCHEZCESPEDES M
MONZO M
ROSELL R
PIFARRE A
CALVO R
LOPEZCABRERIZO MP
ASTUDILLO J
Citation: M. Sanchezcespedes et al., DETECTION OF CHROMOSOME 3P ALTERATIONS IN SERUM DNA OF NON-SMALL-CELLLUNG-CANCER PATIENTS, Annals of oncology, 9(1), 1998, pp. 113-116
Citation: R. Rosell, TENTATIVE STUDIES IN NONSMALL CELL LUNG-CANCER IN JAPAN AND SPAIN, Japanese Journal of Clinical Oncology, 28(8), 1998, pp. 521-522
Citation: R. Rosell et al., THE ACTIVITY OF GEMCITABINE PLUS CISPLATIN IN RANDOMIZED TRIALS IN UNTREATED PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(4), 1998, pp. 27-34
Citation: L. Martinneto et al., CORRELATION OF SPECTROSCOPIC INDICATORS OF HUMIFICATION WITH MEAN ANNUAL RAINFALL ALONG A TEMPERATE GRASSLAND CLIMOSEQUENCE, Geoderma, 81(3-4), 1998, pp. 305-311
Authors:
MARTINEZLOPEZ E
ABAD A
FONT A
MONZO M
OJANGUREN I
PIFARRE A
SANCHEZ JJ
MARTIN C
ROSELL R
Citation: E. Martinezlopez et al., ALLELIC LOSS ON CHROMOSOME 18Q AS A PROGNOSTIC MARKER IN STAGE-II COLORECTAL-CANCER, Gastroenterology, 114(6), 1998, pp. 1180-1187
Authors:
ROSENFELD MR
MALATS N
SCHRAMM L
GRAUS F
CARDENAL F
VINOLAS N
ROSELL R
TORA M
REAL FX
POSNER JB
DALMAU J
Citation: Mr. Rosenfeld et al., SERUM ANTI-P53 ANTIBODIES AND PROGNOSIS OF PATIENTS WITH SMALL-CELL LUNG-CANCER, Journal of the National Cancer Institute, 89(5), 1997, pp. 381-385
Authors:
SANCHEZCESPEDES M
ROSELL R
PIFARRE A
LOPEZCABRERIZO MP
BARNADAS A
SANCHEZ JJ
LORENZO JC
ABAD A
MONZO M
NAVASPALACIOS JJ
Citation: M. Sanchezcespedes et al., MICROSATELLITE ALTERATIONS AT 5Q21, 11P13, AND 11P15.5 DO NOT PREDICTSURVIVAL IN NONSMALL CELL LUNG-CANCER, Clinical cancer research, 3(7), 1997, pp. 1229-1235
Authors:
ROSELL R
PIFARRE A
CALVO R
MAUREL J
LOPEZCABRERIZO MP
MONZO M
Citation: R. Rosell et al., GENETIC SUSCEPTIBILITY LINKED WITH RARE HA-RAS1 ALLELES AND MICROSATELLITE ALTERATIONS IN NONSMALL CELL LUNG-CANCER (NSCLC), European journal of cancer, 33, 1997, pp. 1289-1289